MétaCan
Menu
Back to cohort
Record W7116966294 · doi:10.1002/alz70861_109016

Clinical and Cognitive Correlates of Amyloid‐Related Imaging Abnormalities During Lecanemab Treatment in Early Alzheimer's Disease

2025· article· en· W7116966294 on OpenAlexaboutno aff
Nicole Veloro Tayag, Madelaine Lowery, Neel R Edupuganti

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicIntracerebral and Subarachnoid Hemorrhage Research
Canadian institutionsnot available
Fundersnot available
KeywordsCognitionAsymptomaticDiseaseNeuroimagingClinical PracticeCognitive Assessment System

Abstract

fetched live from OpenAlex

BACKGROUND: Lecanemab, a monoclonal antibody targeting amyloid-β protofibrils, has demonstrated efficacy in reducing amyloid plaque burden and slowing cognitive decline in early Alzheimer's disease (AD). However, treatment is associated with amyloid-related imaging abnormalities (ARIA), including vasogenic edema (ARIA-E) and cerebral microhemorrhages or superficial siderosis (ARIA-H). The cognitive consequences of ARIA remain insufficiently characterized in real-world settings. METHOD: This retrospective cohort study included 92 individuals with mild cognitive impairment or mild AD who received Lecanemab between 2023 and 2025 at a single community memory clinic. All patients had biomarker-confirmed amyloid pathology via plasma pTau217 or amyloid PET imaging. Clinical data extracted included demographics, vascular risk factors, APOE4 carrier status, antithrombotic use, infusion number, ARIA subtype and severity, and serial MRI findings. Cognitive performance was assessed longitudinally using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). The primary objective was to evaluate associations between ARIA characteristics and cognitive trajectories. RESULT: The majority of patients (n = 58, 63%) did not develop ARIA. Among ARIA-positive patients (n = 34, 37%), isolated ARIA-H and combined ARIA-H with ARIA-E were the most prevalent subtypes. ARIA-E resolved in 63% of cases on follow-up imaging, whereas ARIA-H persisted in 60%. Most ARIA events (71%) were asymptomatic and mild to moderate in severity. There was no significant difference in cognitive outcomes between patients with asymptomatic ARIA and those without ARIA (mean MMSE 28.1 vs. 28.5, p = 0.34). However, patients with symptomatic ARIA demonstrated significantly lower follow-up MMSE scores compared to both asymptomatic ARIA and ARIA-negative individuals (mean MMSE 25.0, p = 0.004 and p = 0.02, respectively). A non-significant trend toward lower cognitive scores was observed in those with higher ARIA-H burden. CONCLUSION: In this real-world cohort, symptomatic ARIA-particularly ARIA-H-was associated with measurable cognitive decline. While most ARIA cases were asymptomatic and did not impact cognition, these findings highlight the need for routine neuroimaging surveillance and individualized treatment strategies to optimize safety and cognitive outcomes during Lecanemab therapy. This highlights the need for ongoing assessment of ARIA in clinical practice to enhance the safety and efficacy of amyloid-targeting therapies in early AD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.318
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicIntracerebral and Subarachnoid Hemorrhage ResearchFrench-language works237,207